Swisse boss defends La Trobe deal

Vitamin giant Swisse has hit back at criticism of its deal to give $15 million to La Trobe University for a complementary medicines research centre.

The proposed deal has created a storm of controversy with critics saying it leaves La Trobe researchers open to undue influence and their research without independent oversight.

But Swisse chief executive Radek Sali (pictured) last week told Australian Doctor his company’s approach was no different from the widespread practice of pharmaceutical companies’